Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Inventories — Finished goods: $4,113M in FY2025, up 9.0% from a year earlier. That is the highest of the 11 years on record here.
Latest, FY2025
4,113
Period ended Dec 31, 2025
Change on a year earlier
+9.0%
3,775 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Inventories Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventories — Finished goods ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,113 | +9.0% | Form 10-Q (filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 3,775 | +8.0% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 3,495 | +34.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 2,603 | -28.5% | Form 10-K (filed 2024-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 3,641 | +27.0% | Form 10-K (filed 2023-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 2,867 | +26.6% | Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 2,265 | +0.1% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 2,262 | -21.5% | Form 10-K (filed 2020-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 2,883 | +25.7% | Form 10-K (filed 2019-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 2,293 | -15.5% | Form 10-K (filed 2018-02-22) ↗ |
| FY2015 | Dec 31, 2015 | 2,714 | – | Form 10-K (filed 2017-02-23) ↗ |
Cite this data
StockData. (2026). Pfizer Inventories — Finished goods ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/inv-fg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.